Intuitive Surgical Inc. (ISRG)

575.54
5.71 1.00
NASDAQ : Health Technology
Prev Close 569.83
Open 572.00
Day Low/High 567.09 / 576.99
52 Wk Low/High 360.50 / 619.00
Volume 464.66K
Avg Volume 744.00K
Exchange NASDAQ
Shares Outstanding 116.62M
Market Cap 64.12B
EPS 11.90
P/E Ratio 47.74
Div & Yield N.A. (N.A)
Checking Apple Before Its Earnings

Checking Apple Before Its Earnings

Here are its likely upside and downside targets.

Approaching Correction Country?

Approaching Correction Country?

We have to be very careful about anticipating a major reversal rather than just a bout of profit taking.

Still In the Thick of It

Still In the Thick of It

Earnings season is just getting under way, options expire today -- there's plenty to watch for as this uptrend finds its footing.

Intuitive Surgical numbers raised at JMP

Off the Charts

Off the Charts

Expect choppy action on Friday, which is options expiration.

Conditions Ripe for Selling

Conditions Ripe for Selling

Will a 'sell the news' reaction to earnings take hold?

Two Options Plays for Earnings

Two Options Plays for Earnings

Here's what I'm looking at in GOOG and ISRG.

Don't Fight the Trend

Don't Fight the Trend

Although the market is technically a bit extended right now, that has frequently been a buy signal.

These, at Least, Are Gaining Steam

These, at Least, Are Gaining Steam

Amid a timid rally, I see potential breakouts for these names -- though better broad action would help.

Fitz Bits: Another Bite at Google

Fitz Bits: Another Bite at Google

You might consider taking some stock at these levels.

Defense Is the Best Offense

Defense Is the Best Offense

Playing in the current market is fine, but with volume so light, take quick profits if you get them.

Searching for a Pulse

Searching for a Pulse

It's not that the market action is bad, it just isn't lively enough to support aggressive action.

Tuesday's Unconvincing Session

Tuesday's Unconvincing Session

Volume was tepid, transports landed on their faces, and we lack leadership.

Scrutinize Those Breakouts

Scrutinize Those Breakouts

Some breakouts, like that of Apple lately, cannot be taken at face value -- especially if they lack volume.

Strong Volume Equals a Strong Foundation

Strong Volume Equals a Strong Foundation

EBIX broke out on Tuesday in heavy volume, which hints at institutional buying in this stock.

Easy Does It

Easy Does It

As long as you don't expect much other than random, low-volume action, you'll be fine.

The Mood Is Upbeat

The Mood Is Upbeat

Plenty of stocks are being walked up this morning, albeit on lighter volume.

Intuitive Surgical Looks Interesting

Intuitive Surgical Looks Interesting

It's one of the few charts that seems promising, but market volume across the board is barely on life support.

Market Darlings Are Getting Slaughtered

Market Darlings Are Getting Slaughtered

 Despite everything they are doing right, these stocks are being walloped.

Off the Charts

Off the Charts

Following the European markets and falling after the Fed announcement.

Off the Charts

Off the Charts

Waiting and watching for the FOMC rate decision on Tuesday.

Not Giving Up on This Rally

Not Giving Up on This Rally

The buying lacks conviction, but we have some high-quality setups.

Short-Busting Pattern in Play (Again)

Short-Busting Pattern in Play (Again)

This is such a time-honored pattern that I am surprised there isn't a short-busters triple ETF by now.

Year-End Repairs for Your Portfolio

Year-End Repairs for Your Portfolio

If you took some hard losses this year, here are some strategies for regaining ground.

Apple Is Back to Life

That is the biggest positive in a market subject to mood swings.

Big-Cap Momentum Names in the Lead

Money managers are looking for performance as the focus shifts back to stock picking.

The Focus Stays on Europe

I'd like this market better if there were more momentum and a focus on stock-picking, rather than headlines.

Three Standouts in the Healthcare Space

Three Standouts in the Healthcare Space

Finding strong stocks in this sector still works -- check out these best-of-breed companies.